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Preventing fatal diseases increases healthcare costs: cause
elimination life table approach
Luc Bonneux, Jan J Barendregt, Wilma J Nusselder, Paul J Van der Maas
Abstract
Objectives: To examine whether elimination of fatal
diseases will increase healthcare costs.
Design: Mortality data from vital statistics combined
with healthcare spending in a cause elimination life
table. Costs were allocated to specific diseases through
the various healthcare registers.
Setting and subjects: The population of the
Netherlands, 1988.
Main outcome measures: Healthcare costs of a
synthetic life table cohort, expressed as life time
expected costs.
Results: The life time expected healthcare costs for
1988 in the Netherlands were £56 600 for men and
£80 900 for women. Elimination of fatal
diseases—such as coronary heart disease, cancer, or
chronic obstructive lung disease—increases health›
care costs. Major savings will be achieved only by
elimination of non›fatal disease—such as
musculoskeletal diseases and mental disorders.
Conclusion: The aim of prevention is to spare people
from avoidable misery and death not to save money
on the healthcare system. In countries with low
mortality, elimination of fatal diseases by successful
prevention increases healthcare spending because of
the medical expenses during added life years.
Introduction
In countries with low mortality, healthcare costs—
which are already substantial—are on the rise. Health
promotion, on the basis of the simple idea that by pre›
venting illness, illness related costs will be prevented,
has been hailed as the solution by some.1 It is doubtful,
however, whether eliminating fatal diseases would
cause a decrease in chronic morbidity. Healthcare
needs terminate at death. Surviving means ageing, the
strongest determinant for diseases such as osteoarthri›
tis, osteoporosis and related fractures, cognitive
decline, or loss of vision or hearing.
In demography, the effects of eliminating diseases
are studied by cause elimination life tables.2 In such life
tables a cause of death is eradicated and the life expect›
ancy recalculated. By linking healthcare costs specific
for a disease to the life table population, the
consequences of having eliminated that disease as a
cause of death, as well as of a source of costs, can be
estimated.
Methods
In a previous study all healthcare costs in the
Netherlands in 1988 (39 800 million Dutch guilders
(fl), about £11 400 million at the 1988 exchange rate,
for 14.8 million inhabitants) were allocated to age, sex,
health› care sector, and primary diagnosis on the basis
of comprehensive data on morbidity, mortality, and
direct costs.3–5 About a quarter of all costs could not be
allocated to a primary diagnosis, either through a lack
of information or because of the non›personal nature
of these costs (administration, general public health
services, etc).
The healthcare costs were linked to the Dutch
period life table for men and women for 1986›90.6
The expected costs represent the total costs of the life
table cohort during their lifetime. These costs are
divided by the initial size of the life table cohort—that
is, the population at birth—to yield the life time
expected costs for an individual (see appendix). The
interpretation of life time expected costs is analogous
to the interpretation of life expectancy. The imaginary
life table cohort was subjected to the unchanging costs
of 1988 and the unchanging death rates of 1986›90
until extinction. The life expectancy is the sum of all
the years a life table person is expected to live; the life
time expected costs are the sum of all the healthcare
costs that person is expected to incur during these life
years. To calculate the effect of eradication, a specific
disease was eliminated both as cause of death and as
cause of costs: the cause elimination life table recalcu›
lates life expectancy and life time expected costs as if
the eliminated disease had never existed. The life table
assumed that people lived on average for half a year in
the year of death. In the year that an eliminated cause
of death would have occurred, people are then at risk
of death from other causes during the entire year
(instead of half a year) and remain fully at risk of other
causes for the added life years. Only allocated costs
were considered in the cause elimination life tables.
Because cause elimination life tables are interpreted
as stationary populations before or after the
elimination of a disease7 the costs were not
discounted. Cause specific mortality data were
available for 5 year age groups up to the age of 84.6
After the age of 85, we assumed the cause of death
ratio (deaths from the specific cause divided by all
deaths) and the costs remained constant with rising
age. This assumption underestimates the cost of
added life years in the very old. Specific causes of
death are underregistered at older ages, and health›
care costs increase steadily with age.3–5 8
Results
Life expectancy in the Netherlands in 1986›90 was
73.5 years for men and 80.0 years for women. The life›
time expected costs at birth for all health care totalled
fl198 000 (£56 600) for men and fl283 000 (£80 900)
for women. About fl155 000 (£44 300) for men and
fl219 000 (£62 600) for women was allocated to a
primary diagnosis (table).
The table shows the inverse relation between fatal›
ity and costs: the highly lethal coronary heart diseases,
causing nearly 19% of all deaths, account for only 2.7%
of all healthcare costs. Mental disorders, including psy›
chiatric diseases, mental handicaps, and dementia, are
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together responsible for only 0.6% of all deaths but
account for 26% of the allocated healthcare budget.
Elimination of coronary heart disease would substan›
tially increase the burden on the healthcare budget as
this would save few costs but add a considerable
number of life years. Indeed, life expectancy would
increase by about 1.9 years (2.5%), while costs would
jump 6%. On the other hand, elimination of dementia
would cause no noticeable change in life expectancy
but would save 6% on the healthcare budget.
The elimination of coronary heart disease, cancer,
and chronic obstructive lung disease—the present
targets of health promotion—would augment health›
care costs substantially. The savings yielded by elimina›
tion of costs related to stroke and heart failure
outweigh the costs associated with gains in life expect›
ancy. Cancer is more fatal among men than among
women, consequently the elimination of cancer would
add more life years and therefore more costs among
men.
Elimination of accidents and other unnatural
causes of death adds life years and saves costs, in terms
of both the high burden of morbidity and mortality.
But the table shows that the largest gains are to be
achieved through the elimination of mental disorders
and musculoskeletal diseases: limited sources of lost
life years but major sources of costs.
Discussion
Our analysis shows that lengthening life generally will
increase healthcare needs, particularly needs for long
term nursing care as most life years are added to old
age. This is not a bad thing; prevention can hardly be
blamed if it reaches its target and lowers mortality. Life
saving treatment, such as antibiotic treatment of severe
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Detail All deaths (1986›90)
All allocated costs
(£1000; 1988)
Life expectancy after
elimination (years)
Life time expected
costs (£) after
elimination
Men
None 330 717 (100) 3 755 (100) 73.5 (100) 44 011 (100)
Cardiovascular diseases (390›459): 131 979 (39.9) 480 (12.8) 78.8 (7.1) 46 301 (5.2)
Coronary heart disease (410›414) 69 624 (21.1) 153 (4.1) 76.0 (3.4) 46 674 (6.0)
Stroke (430›438) 24 524 (7.4) 126 (3.4) 74.2 (0.9) 43 477 (−1.2)
Heart failure (428›429) 9 571 (2.9) 51 (1.4) 73.8 (0.4) 43 762 (−0.6)
Cancer (140›208): 101 309 (30.6) 233 (6.2) 77.5 (5.3) 47 657 (8.3)
Lung cancer (162) 36 859 (11.1) 49 (1.3) 74.8 (1.8) 45 683 (3.8)
Colorectal cancer (153›154) 9 510 (2.9) 26 (0.7) 73.8 (0.4) 44 201 (0.4)
Respiratory disease (460›519): 29 257 (8.8) 196 (5.2) 74.3 (1.1) 43 257 (−1.7)
Chronic obstructive lung disease (490›496) 20 154 (6.1) 77 (2.0) 74.1 (0.7) 44 150 (0.3)
Unnatural causes of death (E800›E999): 15 782 (4.8) 205 (5.5) 74.4 (1.2) 42 617 (−3.2)
Traffic accidents (E800›E848) 5 212 (1.6) 58 (1.5) 73.9 (0.5) 43 734 (−0.6)
Mental disorders (290›316): 1 406 (0.4) 1 025 (27.3) 73.6 (0.06) 33 256 (−24.4)
Dementia (290) 870 (0.3) 84 (2.2) 73.6 (0.02) 42 636 (−3.1)
Musculoskeletal diseases (710›739) 1 120 (0.3) 300 (8.0) 73.6 (0.04) 40 812 (−7.3)
Women
None 298 569 (100) 4 930 (100) 80.0 (100) 62 292 (100)
Cardiovascular diseases (390›459): 126 988 (42.5) 502 (10.2) 85.0 (6.3) 68 964 (10.7)
Coronary heart disease (410›414) 48 279 (16.2) 79 (1.6) 81.5 (2.0) 65 994 (5.9)
Stroke (430›438) 35 609 (11.9) 201 (4.1) 81.0 (1.3) 62 263 (−0.05)
Heart failure (428›429) 12 163 (4.1) 71 (1.4) 80.3 (0.4) 62 176 (−0.2)
Cancer (140›208): 76 177 (25.5) 282 (5.7) 83.4 (4.2) 66 339 (6.5)
Lung cancer (162) 5 650 (1.9) 10 (0.2) 80.2 (0.3) 62 717 (0.7)
Colorectal cancer (153›154) 10 642 (3.6) 32 (0.6) 80.3 (0.5) 62 810 (0.8)
Respiratory disease (460›519): 19 152 (6.4) 154 (3.1) 80.5 (0.7) 62 101 (−0.3)
Chronic obstructive lung disease (490›496) 7 928 (2.7) 79 (1.6) 80.2 (0.3) 62 340 (0.1)
Unnatural causes of death (E800›E999): 11 409 (3.8) 280 (5.7) 80.5 (0.7) 59 183 (−5.0)
Traffic accidents (E800›E848) 2 168 (0.7) 39 (0.8) 80.1 (0.2) 62 045 (−0.4)
Mental disorders (290›316): 2 687 (0.9) 1 220 (24.8) 80.0 (0.08) 46 853 (−24.8)
Dementia (290) 2 492 (0.8) 301 (6.1) 80.0 (0.07) 57 185 (−8.2)
Musculoskeletal diseases (710›739) 3 084 (1.0) 486 (9.8) 80.1 (0.1) 56 165 (−9.8)
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infections or oral rehydration in severe diarrhoea, has
the same consequences. Indeed, we firmly believe that
primary prevention, such as an effective antismoking
policy, is an excellent buy. But that does not imply that
no bill has to be paid. Our paper contradicts popular
belief that prevention might “prevent” healthcare
costs.1 Acute medical costs may be averted, but the
considerable needs for long term nursing care of frail
elderly people can but increase.
Eliminating causes in a life table demonstrates an
unquestionable truth: we all have to die. If we eliminate
a specific cause of death, we simply die later from
another. In the meantime we grow older, become gen›
erally more disabled, and need more care.9 In the
Netherlands, cardiovascular diseases and cancer were
jointly responsible for nearly 70% of all deaths, yet
accounted for a mere 17% of all healthcare costs,
whereas the largely non›fatal diseases of the brain,
joints, and bones, causing under 2% of all deaths, gen›
erated 35% of all costs (see table). If fatal diseases are
eliminated, healthcare costs during the added life years
swamp the savings yielded by the eliminated disease,
even if the intervention is radical and without extra
costs. At any age, the imaginary population of the
cause elimination life table spends less on health care
per person yet total costs increase because more
people remain alive, surviving to older ages when
chronic morbidity and demands for health care are
highest (figure).
As the debate has focused on healthcare costs,1 we
took into account only medical costs. The non›medical
costs of added life years, such as pensions and
non›medical care for elderly people, would far
outweigh any non›medical costs of disease and death.10
In view of the fact that our cost data are
comprehensive, we were able to consider all health›
care spending, including long term nursing care.3–5
Previous studies have shown that in the United States
payments for acute medical care are higher in the year
before death, irrespective of age at death.11 Our results
do not contradict these findings but demonstrate the
high burden of chronic care for non›fatal diseases,
which are not determined by death.
Cause elimination life tables are simple mathemati›
cal models based on the assumption of the independ›
ence of diseases. Only primary diagnoses are taken into
account, while comorbidity is ignored. In real life, many
diseases are not independent, and death is often the end
of a complex process. Insights are garnered from parsi›
monious theoretical experiments, however, precisely
because they simplify a complicated reality. Taking all
relevant disease interactions into account would
increase needs for data and complexity of models intol›
erably but would not change the conclusions in a mean›
ingful way. Indeed, only when a disease process can be
postponed without postponing mortality can morbidity
and healthcare needs be “compressed” by prevention.2
From a humanitarian point of view, life is
preferable to death and health to illness.13 The aim of
health care is not to save money but to save people
from preventable suffering and death. Moreover, the
medical costs of added life years are trivial. Life exten›
sion would cost about £890 to £1400 per life year
added, which few would consider unacceptable. But if
prevention is used as an argument for constraining
future healthcare expenditures, the medical expenses
in the added life years are not insignificant and cannot
be ignored. There is no evidence that healthcare costs
are increasing because citizens live unhealthier lives. In
fact, quite the contrary would seem to be the case.
We have become increasingly successful at post›
poning mortality until advanced ages. Old age,
however, is associated not only with impending death
but also with dementia, social isolation, osteoarthritis,
hip fractures, and loss of vision and hearing. Even
humble progress in disease prevention would have a
tangible impact. Any potential savings on healthcare
costs would be icing on that cake.
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Appendix
Life time expected costs (LEC) are calculated by
LEC = Ó
x
( Cx
Nx
* Lx)
where Cx is the cost of all causes in the age interval
(x, x + 1). Nx is the number of people in the age interval
(x, x + 1) and Lx the person years lived in the age inter›
val (x, x + 1).
Eliminating a cause of death is based on the
actuarial assumption that people dying from the
specific cause in the age interval x, x + 1 were
considered to have been at a 0.5 year risk of dying from
all other causes. The risk of dying at age x from all
Key messages
+ In countries with low mortality prevention of
fatal diseases adds life years predominantly to
old age, when disabling conditions are
prevalent
+ If fatal diseases are eliminated, the medical costs
of life extension at old age will generally be
higher than the costs prevented. Prevention of
disabling conditions, particularly mental
disorders and musculoskeletal conditions,
might both lower healthcare costs and improve
public health
+ The aim of prevention is to save people from
preventable morbidity and mortality not to save
money
+ For the time being, prevention of disability
should have the highest priority for future
research
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other causes, adjusted for competing causes, (qx,›á) is
therefore
qx,›á =
dx,›á
lx–
1
2 dx,á
where dx, is the number of deaths in age interval (x,
x + 1) due to the cause á, dx,›á is the number of deaths
in age interval (x, x + 1) due to all other causes than á,
and lx is the number of survivors to age x (of the all
causes life table cohort). The life table cohort is at risk
for this adjusted force of mortality from other causes
until extinction.2
The expected life time costs at birth after
elimination of cause á (LEC›á) are given by
LEC›á = Óx (
Cx,›á
Nx
* Lx,›á)
where Cx,›á represents the costs in the age interval
(x, x + 1) made for all diseases other than á and Lx,›á
gives the life years lived in the age interval (x, x + 1)
after elimination of cause á.
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First sexual intercourse: age, coercion, and later regrets
reported by a birth cohort
Nigel Dickson, Charlotte Paul, Peter Herbison, Phil Silva
Abstract
Objectives: To investigate how age at first sexual
intercourse is related to the reported circumstances
and to determine how these corresponded to views in
early adulthood about its timing.
Design: Cross sectional study within a birth cohort
using a questionnaire presented by computer.
Setting: Dunedin, New Zealand in 1993›4.
Subjects: 477 men and 458 women enrolled in the
Dunedin Multidisciplinary Health and Development
Study, comprising 92% of survivors of the cohort.
Results: The median age at first intercourse was 17
years for men and 16 years for women. Only one man
(0.2%) but 30 (7%) women reported being forced to
have intercourse on the first occasion. For women,
there were increasing rates of coercion with younger
age at first intercourse. More men than women
reported that they and their partner were equally
willing (77% (316/413) v 53% (222/419)). Mutual
willingness of both partners was greater for those who
reported that it was also the first time for their
partner. Timing of first intercourse was considered
about right by 49% (200/411) of men and 38%
(148/388) of women. Many women (54% (211/388)
reported that they should have waited longer, and this
rose to 70% (90/129) for women reporting
intercourse before age 16.
Conclusions: Most women regretted having sexual
intercourse before age 16. First intercourse at younger
ages is associated with risks that are shared unequally
between men and women. This information is
important to young people themselves.
Introduction
In many developed countries, including New Zealand,
there has been a substantial lowering of the age at first
sexual intercourse over the past 30 years.1 Early
intercourse carries increased risks of sexually transmit›
ted diseases and unwanted pregnancies, which may
result in long term health and social disadvantages.2 3
Individual (physical and social) and societal factors
influence adolescent sexual behaviour.4 Children are
exposed to sexual images through the media. Social
and peer pressure may arise from the portrayal of sex
as glamorous, pleasurable, and adult, while negative
consequences and the responsibilities involved in
sexual relationships are seldom portrayed.5 Although
more liberal attitudes of society have influenced the
behaviour of the current generation of young people,
few studies have considered the views of young people
themselves about early intercourse4 6–8 even though
they have to bear the consequences.
The aim of our study was to investigate the circum›
stances of first sexual intercourse and to determine
how these corresponded to views in early adulthood
about its timing. Of interest was the extent of the
differences in views between young men and women
who reported similar sexual behaviour.
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